So, you have managed to shed 30 pounds with the help of one of the new blockbuster GLP-1 drugs, but as the holidays ...

Opioid use disorder (OUD) treatment continued to increase in intervention clinics in the third year of implementation ...

Menopausal hormone therapy (mHT) is not associated with long-term cognitive effects versus placebo, according to a stu ...

An estimated 100,429 youth are living with pediatric inflammatory bowel disease (PIBD) in the United States, according ...

The U.S. Food and Drug Administration has expanded the age indication for Nerivio, making it the first and only remote ...

More than half of all U.S. adults are eligible for semaglutide therapy, according to a research letter published onlin ...

Recovery from anti-NMDA receptor (anti-NMDAR) encephalitis continues for three years, but deficits persist, according ...

Younger and middle-aged patients seem to be disproportionately affected by neurologic manifestations of postacute sequ ...

An initial strategy of catheter ablation leads to a lower risk for a composite primary end point than antiarrhythmic d ...

Combination treatment with entinostat and nivolumab results in durable responses in a small subset of patients with ad ...

It looks like Long COVID takes a bigger toll on younger and middle-aged adults than seniors, a new study finds.Researchers at ...